T. Moriwake, Yusuke Tominaga, Satoshi Katayama, H. Kaku, Ichiro Tsuboi, K. Yoshinaga, T. Yamanoi, Tatsushi Kawada, T. Sadahira, T. Iwata, S. Nishimura, K. Bekku, Y. Katayama, Motoo Araki
2026.2.1BJUI Compass
tlooto Summary
The objective of this study is to evaluate the safety and efficacy of Rezūm water vapour energy therapy (WAVE) in Japanese patients with benign prostatic hyperplasia and to validate the Okayama University Modified Clavien‐Dindo classification (OU‐mCD) for perioperative hematuria.
Abstract
The objective of this study is to evaluate the safety and efficacy of Rezūm water vapour energy therapy (WAVE) in Japanese patients with benign prostatic hyperplasia (BPH) continuing antithrombotic therapy and to validate the Okayama University Modified Clavien‐Dindo classification (OU‐mCD) for perioperative hematuria.
Citation format
MORIWAKE, T., et al. Safety and efficacy of rezūm water vapour energy therapy in BPH patients receiving antithrombotic therapy: A japanese single‐centre experience. BJUI Compass, 2026, 7(2): e70170.